Literature DB >> 19827835

Highly effective binding of viologens by p-sulfonatocalixarenes for the treatment of viologen poisoning.

Kui Wang1, Dong-Sheng Guo, Hong-Qing Zhang, Dong Li, Xi-Long Zheng, Yu Liu.   

Abstract

Viologens are showing an increasing number of scientific and technical applications in addition to their use as herbicides. However, their high toxicity poses considerable risks to human health, society, and the environment. In this context, we propose a new therapeutic protocol for the treatment of viologen poisoning. The mechanism of this new protocol is based on host-guest chemistry and involves the effective inhibition of viologen toxicity by the complexation of p-sulfonatocalix[n]arenes. NMR, ITC, and X-ray crystallography studies indicated that p-sulfonatocalix[n]arenes could form highly stable complexes with viologens. Electrochemical results showed that the highly effective binding could induce the reduction potentials of viologens to shift to more negative values. Further studies in mice showed that the ingestion of p-sulfonatocalix[n]arenes significantly decreased the mortality rate of viologen-poisoned mice with lung and liver protection. As a result, p-sulfonatocalix[n]arenes may have potential application in the clinical treatment of viologen poisoning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19827835     DOI: 10.1021/jm900811z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  In Vitro and In Vivo Sequestration of Methamphetamine by a Sulfated Acyclic CB[n]-Type Receptor.

Authors:  Adam T Brockett; Chunlin Deng; Michael Shuster; Suvenika Perera; Delaney DiMaggio; Ming Cheng; Steven Murkli; Volker Briken; Matthew R Roesch; Lyle Isaacs
Journal:  Chemistry       Date:  2021-10-27       Impact factor: 5.236

2.  Anthracene-Walled Acyclic CB[n] Receptors: in vitro and in vivo Binding Properties toward Drugs of Abuse.

Authors:  Delaney DiMaggio; Adam T Brockett; Michael Shuster; Steven Murkli; Canjia Zhai; David King; Brona O'Dowd; Ming Cheng; Kimberly Brady; Volker Briken; Matthew R Roesch; Lyle Isaacs
Journal:  ChemMedChem       Date:  2022-03-15       Impact factor: 3.540

3.  Spectral, Electrochemical and Computational Investigations of Binding of n-(4-Hydroxyphenyl)-imidazole with p-Sulfonatocalix[4]arene.

Authors:  Marimuthu Senthilkumaran; Kalimuthu Maruthanayagam; Ganesan Vigneshkumar; Ramesh Kumar Chitumalla; Joonkyung Jang; Paulpandian Muthu Mareeswaran
Journal:  J Fluoresc       Date:  2017-09-08       Impact factor: 2.217

Review 4.  Supramolecular hosts as in vivo sequestration agents for pharmaceuticals and toxins.

Authors:  Chun-Lin Deng; Steven L Murkli; Lyle D Isaacs
Journal:  Chem Soc Rev       Date:  2020-10-12       Impact factor: 54.564

5.  Sequestration of pyridinium herbicides in plants by carboxylated pillararenes possessing different alkyl chains.

Authors:  Mian Tang; Qiang Bian; Ying-Ming Zhang; Muhammad Arif; Qiong Luo; Shuzhen Men; Yu Liu
Journal:  RSC Adv       Date:  2020-09-22       Impact factor: 4.036

Review 6.  Host-Guest Chemistry in Supramolecular Theranostics.

Authors:  Guocan Yu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2019-05-15       Impact factor: 11.556

7.  A Synthetic Receptor as a Specific Antidote for Paraquat Poisoning.

Authors:  Xiangjun Zhang; Xiaoqiu Xu; Shengke Li; Lanlan Li; Jianxiang Zhang; Ruibing Wang
Journal:  Theranostics       Date:  2019-01-21       Impact factor: 11.556

Review 8.  Recent advances in supramolecular antidotes.

Authors:  Hang Yin; Xiangjun Zhang; Jianwen Wei; Siyu Lu; David Bardelang; Ruibing Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

9.  In Vitro and In Vivo Sequestration of Phencyclidine by Me4 Cucurbit[8]uril*.

Authors:  Steven Murkli; Jared Klemm; Adam T Brockett; Michael Shuster; Volker Briken; Matthew R Roesch; Lyle Isaacs
Journal:  Chemistry       Date:  2021-01-19       Impact factor: 5.236

10.  Amphiphilic p-sulfonatocalix[4]arene as "drug chaperone" for escorting anticancer drugs.

Authors:  Yi-Xuan Wang; Dong-Sheng Guo; Yong-Chao Duan; Yong-Jian Wang; Yu Liu
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.